Round Table
Access to therapy for patients with a rare disease: from studies to approval, reimbursement and optimal use
Introduction:
Prof. René Westhovens (President of the Colleges for Orphan Drugs, National Institute for Health and Disability Insurance (INAMI-RIZIV), Belgium)
Panelists:
René Westhovens / Davide Pareyson / Maike Dohrn / Alexandre Hoyau